Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-17
SponsorDuke University

About this trial

This is a single-center, randomized, SHAM-controlled, parallel assignment, double-masked,8-week interventional study among children aged 8-17 years (not yet 18 years old) of age with obesity and asthma. (n=60), recruited from Duke Health Center Creekstone, to test the effectiveness of inspiratory muscle rehabilitation (IMR) as an acceptable add-on intervention to reduce dyspnea (feeling short-of-breath or breathless) and to promote greater activity in children with obesity and asthma.

Clinic to test the effectiveness of inspiratory muscle rehabilitation (IMR) as an acceptable add-on intervention to reduce dyspnea (feeling short-of-breath or breathless) and to promote greater activity in children with obesity

Eligibility criteria

Qualifiers

Documented informed consent from legal guardian and assent from participant as appropriate.

Children 8 to 17 years of age with obesity (BMI ≥ 95th percentile for age and sex) and mild asthma.

Participants (or parent/guardian) must have access to the internet and an approved smart device/computer.

Child must have a designated caregiver who expresses a commitment to encourage the participant to complete the study procedures.

Disqualifiers

Prior intubation for asthma

Current self-reported pregnancy or planning to become pregnant.

Have an FEV1 < 50% of predicted at screening

History of lung surgery in the past two years,

Trial design

Treatments tested in this trial

  • Pro2 - 60% of participant's MIP
  • Pro2 - 15% of participant's MIP

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Duke University

Lead sponsor

American Lung Association

Collaborator